Sadafumi Kawamura

Natori-shi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.

Journal: International journal of clinical oncology

Published: September 17, 2024

CD271 promotes proliferation and migration in bladder cancer.

CD271 promotes proliferation and migration in bladder cancer.

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Published: October 02, 2023

Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study.

Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study.

Journal: International journal of clinical oncology

Published: April 03, 2023

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.

Journal: Cancer medicine

Published: March 31, 2023

Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.

Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 21, 2023

Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.

Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 29, 2023

Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study.

Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study.

Journal: Cancer medicine

Published: June 22, 2022

Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.

Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.

Journal: Cancer science

Published: March 18, 2022

Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Journal: The Prostate

Published: February 28, 2022

A novel 8.57-kb deletion of the upstream region of PRKAR1A in a family with Carney complex.

A novel 8.57-kb deletion of the upstream region of PRKAR1A in a family with Carney complex.

Journal: Molecular genetics & genomic medicine

Published: November 25, 2021

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: August 17, 2021

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.

Journal: International journal of clinical oncology

Published: August 02, 2021

Showing 1-12 of 59

Last Updated: 09/26/2026